SCHEMBL32669999

SCHEMBL32669999

CSCc1cc(/C(O)=C(\C#N)C(=O)N(C)Cc2cc(Cl)ccc2F)cc([N+](=O)[O-])c1O

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FTO Q9C0B1 9/20 0.49
COMT P21964 7/20 0.49
THRB P10828 2/20 0.33
ABL1 P00519 1/20 0.33
BCR P11274 1/20 0.33
MEN1 O00255 2/20 0.32
LMNA P02545 2/20 0.32
CYP2C9 P11712 2/20 0.32
KMT2A Q03164 2/20 0.32
GPR35 Q9HC97 2/20 0.32
ABCC3 O15438 1/20 0.32
ABCC4 O15439 1/20 0.32
ABCB11 O95342 1/20 0.32
TTR P02766 2/20 0.32
KDM4E B2RXH2 1/20 0.32
GMNN O75496 1/20 0.32
ALDH1A1 P00352 1/20 0.32
TP53 P04637 1/20 0.32
CYP3A4 P08684 1/20 0.32
MAPT P10636 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32669731 0.91 FTO (0.55) FTOCOMTTHRBMEN1LMNA
SCHEMBL32670100 0.91 FTO (0.52) FTOCOMTTHRBMEN1LMNA
SCHEMBL32669701 0.90 FTO (0.62) FTOCOMTTHRBMEN1LMNA
SCHEMBL32669721 0.89 FTO (0.50) FTOCOMTTHRBMEN1LMNA
SCHEMBL32669566 0.88 FTO (0.49) FTOCOMTTHRBMEN1LMNA
SCHEMBL32669635 0.86 S1PR3 (0.36) FTOCOMTS1PR3
SCHEMBL32669602 0.86 FTO (0.50) FTOCOMTTHRBMEN1LMNA
SCHEMBL32669722 0.86 FTO (0.50) FTOCOMTMEN1KMT2ATTR
SCHEMBL32670141 0.85 FTO (0.63) FTOCOMTMEN1LMNACYP2C9
SCHEMBL32669510 0.85 FTO (0.49) FTOCOMTTHRBMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260035341-A1 FTO INHIBITORS RPXDS CO LTD (CN) 2026-02-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260035341-A1 FTO INHIBITORS FTO, LDLR, GPR119 FTO 1/4885COMT 52/4885THRB 355/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.